HIV-associated malignancies.

B. Safai,B. Dias,J. Schwartz,I. Boulier

Antibiotics and Chemotherapy

Abstract:

What problem does this paper attempt to address?

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases

Xiaopeng Ai,Peiling Yu,Lixia Peng,Liuling Luo,Jia Liu,Shengqian Li,Xianrong Lai,Fei Luan,Xianli Meng

DOI: https://doi.org/10.3389/fphar.2021.762654

IF: 5.6

2021-11-03

Frontiers in Pharmacology

Abstract:Traditional Chinese medicine plays a significant role in the treatment of various diseases and has attracted increasing attention for clinical applications. Vascular diseases affecting vasculature in the heart, cerebrovascular disease, atherosclerosis, and diabetic complications have compromised quality of life for affected individuals and increase the burden on health care services. Berberine, a naturally occurring isoquinoline alkaloid form Rhizoma coptidis , is widely used in China as a folk medicine for its antibacterial and anti-inflammatory properties. Promisingly, an increasing number of studies have identified several cellular and molecular targets for berberine, indicating its potential as an alternative therapeutic strategy for vascular diseases, as well as providing novel evidence that supports the therapeutic potential of berberine to combat vascular diseases. The purpose of this review is to comprehensively and systematically describe the evidence for berberine as a therapeutic agent in vascular diseases, including its pharmacological effects, molecular mechanisms, and pharmacokinetics. According to data published so far, berberine shows remarkable anti-inflammatory, antioxidant, antiapoptotic, and antiautophagic activity via the regulation of multiple signaling pathways, including AMP-activated protein kinase (AMPK), nuclear factor κB (NF-κB), mitogen-activated protein kinase silent information regulator 1 (SIRT-1), hypoxia-inducible factor 1α (HIF-1α), vascular endothelial growth factor phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), janus kinase 2 (JAK-2), Ca 2+ channels, and endoplasmic reticulum stress. Moreover, we discuss the existing limitations of berberine in the treatment of vascular diseases, and give corresponding measures. In addition, we propose some research perspectives and challenges, and provide a solid evidence base from which further studies can excavate novel effective drugs from Chinese medicine monomers.

pharmacology & pharmacy
Berberine: a potential phytochemical with multispectrum therapeutic activities

Parameswara Rao Vuddanda,Subhashis Chakraborty,Sanjay Singh

DOI: https://doi.org/10.1517/13543784.2010.517745

2010-09-13

Expert Opinion on Investigational Drugs

Abstract:IMPORTANCE OF THE FIELD: The use of traditional medicines of natural origin is being encouraged for the treatment of chronic disorders, as synthetic drugs in such cases may cause unpredictable adverse effects. Berberine, a traditional plant alkaloid, is used in Ayurvedic and Chinese medicine for its antimicrobial and antiprotozoal properties. Interestingly, current clinical research on berberine has revealed its various pharmacological properties and multi-spectrum therapeutic applications.AREAS COVERED IN THIS REVIEW: An extensive search in three electronic databases (Unbound Medline, PubMed and ScienceDirect) and internet search engines (Scirus and Google Scholar) were used to identify the clinical studies on berberine, without any time constraints. This review elaborates the recent studies which reveal that with time, the drug has evolved with superior therapeutic activities. In addition, this review will also attract the attention of formulation scientists towards the issues and challenges associated in its drug delivery and the probable approaches that may be explored to help patients reap the maximum benefit of this potentially useful drug.WHAT THE READER WILL GAIN: A relatively large number of studies discussed here have revealed the possible areas where this phytochemical constituent can exhibit its therapeutic activities in the treatment of chronic ailments or diseases including diabetes, cancer, depression, hypertension and hypercholesterolemia.TAKE HOME MESSAGE: The potential of the drug remains to be harvested by designing a suitable formulation that could overcome its inherent low bioavailability.

pharmacology & pharmacy
Berberine: A Promising Treatment for Neurodegenerative Diseases

Ziqian Cheng,Chenglan Kang,Songtian Che,Jingyun Su,Qihan Sun,Tongtong Ge,Yi Guo,Jiayin Lv,Zhihui Sun,Wei Yang,Bingjin Li,Xin Li,Ranji Cui

DOI: https://doi.org/10.3389/fphar.2022.845591

IF: 5.6

2022-05-21

Frontiers in Pharmacology

Abstract:Berberine, as a natural alkaloid compound, is characterized by a diversity of pharmacological effects. In recent years, many researches focused on the role of berberine in central nervous system diseases. Among them, the effect of berberine on neurodegenerative diseases has received widespread attention, for example Alzheimer's disease, Parkinson's disease, Huntington's disease, and so on. Recent evidence suggests that berberine inhibits the production of neuroinflammation, oxidative, and endoplasmic reticulum stress. These effects can further reduce neuron damage and apoptosis. Although the current research has made some progress, its specific mechanism still needs to be further explored. This review provides an overview of berberine in neurodegenerative diseases and its related mechanisms, and also provides new ideas for future research on berberine.

pharmacology & pharmacy
Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy

Cuipeng Zhu,Kaiqi Li,Xiao-Xu Peng,Tong-Jia Yao,Zi-Yu Wang,Ping Hu,Demin Cai,Hao-Yu Liu

DOI: https://doi.org/10.3389/fimmu.2022.1083788

IF: 7.3

2022-12-07

Frontiers in Immunology

Abstract:Berberine (BBR), an isoquinoline alkaloid extracted from Coptidis Rhizoma, has a long history of treating dysentery in the clinic. Over the past two decades, the polytrophic, pharmacological, and biochemical properties of BBR have been intensively studied. The key functions of BBR, including anti-inflammation, antibacterial, antioxidant, anti-obesity, and even antitumor, have been discovered. However, the underlying mechanisms of BBR-mediated regulation still need to be explored. Given that BBR is also a natural nutrition supplement, the modulatory effects of BBR on nutritional immune responses have attracted more attention from investigators. In this mini-review, we summarized the latest achievements of BBR on inflammation, gut microbes, macrophage polarization, and immune responses associated with their possible tools in the pathogenesis and therapy of ulcerative colitis and cancer in recent 5 years. We also discuss the therapeutic efficacy and anti-inflammatory actions of BBR to benefit future clinical applications.

immunology
Pharmacological effects of berberine and its derivatives: a patent update

Yifeng Jin,Daulat B. Khadka,Won-Jea Cho

DOI: https://doi.org/10.1517/13543776.2016.1118060

2015-12-04

Expert Opinion on Therapeutic Patents

Abstract:INTRODUCTION: A number of plant-derived agents are used in many therapeutic areas. Berberine, an important protoberberine alkaloid, is present in a number of medicinal plants that have been widely used in traditional Chinese medicine for hundreds of years. Modern research has shown that berberine and its derivatives display several pharmacological effects through various mechanisms.AREAS COVERED: This review discusses recent and mostly Chinese patents that report the synthesis of berberine, berberine derivatives and berberine salts, and methods of preparation for formulations (traditional Chinese medicine) containing herbal components rich in berberine, along with their applications. The review covers several therapeutic effects of berberine, its derivatives and pharmaceutical formulations against cancer, obesity, diabetes, inflammation, atherosclerosis, Alzheimer's disease, rheumatoid arthritis and cardiovascular diseases. In addition, the mechanisms underlying the pharmacological effects are discussed.EXPERT OPINION: Modification of the functional groups of berberine has a significant effect on the pharmacological activity. However, studies on altering the atoms and size of the berberine skeleton are rare. Thus, it may be beneficial to initiate a drug development program focused on inserting heterocyclic rings of different sizes into berberine. Furthermore, structural modification to improve the safety, efficacy and selectivity is necessary to promote the use of berberine-based drugs in clinical settings.

pharmacology & pharmacy,chemistry, medicinal
The complexity of ranking

D. Huynh

DOI: https://doi.org/10.1109/SCT.1988.5280

1988-06-14

Abstract:It is shown that ranking languages accepted by one-way unambiguous auxiliary pushdown automata are in NC/sup (2)/. Negative results about ranking for several classes of simple languages are proved. It is shown that C is rankable in deterministic polynomial time if P= Hash P, where C is any of the following classes of languages: (1) languages accepted by logtime-bounded nondeterministic Turing machines; (2) languages accepted by (uniform) families of unbounded fan-in circuits of constant depth and polynomial size; (3) languages accepted by two-way deterministic finite automata; (4) languages accepted by multihead deterministic finite automata; (5) languages accepted by one-way nondeterministic logspace-bounded Turing machines; and (6) finitely ambiguous linear context-free languages.<<ETX>>
Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential

Dan-Na Huang,Fang-Fang Wu,Ai-Hua Zhang,Hui Sun,Xi-Jun Wang,Dan-na Huang,Fang-fang Wu,Ai-hua Zhang,Xi-jun Wang

DOI: https://doi.org/10.1016/j.phrs.2021.105667

IF: 10.334

2021-07-01

Pharmacological Research

Abstract:Rheumatoid arthritis is a systemic autoimmune disorder involved in persistent synovial inflammation. Berberine is a nature-derived alkaloid compound with multiple pharmacological activities in different pathologies, including RA. Recent experimental studies have clarified several determinant cellular and molecular targets of BBR in RA, and provided novel evidence supporting the promising therapeutic potential of BBR to combat RA. In this review, we recapitulate the therapeutic potential of BBR and its mechanism of action in ameliorating RA, and discuss the modulation of gut microbiota by BBR during RA. Collectively, BBR might be a promising lead drug with multi-functional activities for the therapeutic strategy of RA.

pharmacology & pharmacy
Berberine influences multiple diseases by modifying gut microbiota

Fujie Yang,Rongmao Gao,Xiaoxiu Luo,Rongan Liu,Daqian Xiong

DOI: https://doi.org/10.3389/fnut.2023.1187718

2023-08-03

Abstract:Berberine (BBR) is an isoquinoline alkaloid that is widely distributed in the plant kingdom and is commonly found in Coptis chinensis Franch. It has low bioavailability, but it can interact with gut microbiota and affect a variety of diseases. The effects of BBR in diabetes, hyperlipidemia, atherosclerosis, liver diseases, intestinal diseases, mental disorders, autoimmune diseases, and other diseases are all thought to be related to gut microbiota. This review systematically and comprehensively summarize these interactions and their effects, and describes the changes of gut microbiota after the intervention of different doses of berberine and its potential clinical consequences, in order to provide a basis for the rational application of BBR in the future clinical treatment.
Pharmacological effects of Berberine – A Chinese medicine, against xenobiotics toxicity

Annu Phogat,Jagjeet Singh,Vinay Malik

DOI: https://doi.org/10.1016/j.prmcm.2024.100507

2024-12-01

Pharmacological Research - Modern Chinese Medicine

Abstract:Introduction Traditional Chinese medicine has used plant-derived natural antioxidants from herbs since ages. Berberine is an iso-quinoline-based alkaloid found in various medicinal herbs: Coptis chinensis (Huanglian), Phellodendron amurense (Huangbai) and used in traditional Chinese medicine as decoctions: ‘Xie Xin’ and ‘Huanglian Jiedu’. It has been used since long to treat inflammation, auto-immune diseases and dysentery. Studies have also confirmed its antioxidative, anti-inflammatory, anti-apoptotic, and pharmacological properties. Still, there is a gap between the preclinical significance and clinical efficacy of Berberine against organ toxicity. Thus, the present review summarises the ameliorative potential of Berberine against free radicals-mediated oxidative stress, cholinergic stress, inflammation, mitochondrial dysfunctions, and apoptosis. Methods Various scientific research articles in Google Scholar, PubMed, Scopus, Web of Science, and ScienceDirect, were explored to find the pharmacological effects of Berberine. More than 80 articles since 2010 were explored among which 40 were shortlisted with the keywords: Berberine followed by ‘mechanism,’ ‘ameliorative properties,’ ‘pharmacological properties,’ ‘antioxidant; Berberine against ‘pesticide toxicity’, ‘heavy metal toxicity’ ‘nephrotoxicity’ ‘hepatotoxicity’ ‘neurotoxicity’. The thus selected research articles were carefully read to summarise the latest and most recent developments in writing of this review. Results The structural and functional diversity of Berberine is responsible for the protective efficacy against organ toxicity. The molecular mechanism of Berberine suggests attenuation of oxidative stress, regulation of endogenous antioxidants, and activation of signaling pathways, including PPARɣ/PGC-1α, HNF4α/MTTP, PTEN/Akt, Nrf-2/HO-1/MnSOD, and SIRT1/P66Shc along with inhibition of NF-κB translocation; can ameliorate organ dysfunctioning. Discussion The current review summarises a baseline and preclinical evidence comprising their mechanistic bases, highlighting the ethnopharmacological applications of Berberine for both traditional Chinese medicine and modern therapeutics. This evaluation will give the crucial insight essential for toxicological and pharmacokinetic research on human models to verify the safety issues and confirm the effects of active components of Berberine in the body in a clinical context.
Anti‐inflammatory and immune‐modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation

Seyed‐Morteza Ehteshamfar,Masoume Akhbari,Jalil Tavakol Afshari,Motahareh Seyedi,Banafsheh Nikfar,Abbas Shapouri‐Moghaddam,Erfan Ghanbarzadeh,Amir Abbas Momtazi‐Borojeni

DOI: https://doi.org/10.1111/jcmm.16049

2020-11-01

Journal of Cellular and Molecular Medicine

Abstract:Autoreactive inflammatory CD4+ T cells, such as T helper (Th)1 and Th17 subtypes, have been found to associate with the pathogenesis of autoimmune disorders. On the other hand, CD4+ Foxp3+ T regulatory (Treg) cells are crucial for the immune tolerance and have a critical role in the suppression of the excessive immune and inflammatory response promoted by these Th cells. In contrast, dendritic cells (DCs) and macrophages are immune cells that through their inflammatory functions promote autoreactive T‐cell responses in autoimmune conditions. In recent years, there has been increasing attention to exploring effective immunomodulatory or anti‐inflammatory agents from the herbal collection of traditional medicine. Berberine, an isoquinoline alkaloid, is one of the main active ingredients extracted from medicinal herbs and has been shown to exert various biological and pharmacological effects that are suggested to be mainly attributed to its anti‐inflammatory and immunomodulatory properties. Several lines of experimental study have recently investigated the therapeutic potential of berberine for treating autoimmune conditions in animal models of human autoimmune diseases. Here, we aimed to seek mechanisms underlying immunomodulatory and anti‐inflammatory effects of berberine on autoreactive inflammatory responses in autoimmune conditions. Reported data reveal that berberine can directly suppress functions and differentiation of pro‐inflammatory Th1 and Th17 cells, and indirectly decrease Th cell‐mediated inflammation through modulating or suppressing other cells assisting autoreactive inflammation, such as Tregs, DCs and macrophages.

cell biology,medicine, research & experimental
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota

Shengjie Yang,Dan Li,Zongliang Yu,Yujuan Li,Min Wu

DOI: https://doi.org/10.3389/fphar.2021.709629

IF: 5.6

2021-07-09

Frontiers in Pharmacology

Abstract:Atherosclerosis (AS), especially atherosclerotic cardiovascular diseases (ASCVDs), and metabolic diseases (such as diabetes, obesity, dyslipidemia, and nonalcoholic fatty liver disease) are major public health issues worldwide that seriously threaten human health. Exploring effective natural product-based drugs is a promising strategy for the treatment of AS and metabolic diseases. Berberine (BBR), an important isoquinoline alkaloid found in various medicinal plants, has been shown to have multiple pharmacological effects and therapeutic applications. In view of its low bioavailability, increasing evidence indicates that the gut microbiota may serve as a target for the multifunctional effects of BBR. Under the pathological conditions of AS and metabolic diseases, BBR improves intestinal barrier function and reduces inflammation induced by gut microbiota-derived lipopolysaccharide (LPS). Moreover, BBR reverses or induces structural and compositional alterations in the gut microbiota and regulates gut microbe-dependent metabolites as well as related downstream pathways; this improves glucose and lipid metabolism and energy homeostasis. These findings at least partly explain the effect of BBR on AS and metabolic diseases. In this review, we elaborate on the research progress of BBR and its mechanisms of action in the treatment of AS and metabolic diseases from the perspective of gut microbiota, to reveal the potential contribution of gut microbiota to the multifunctional biological effects of BBR.

pharmacology & pharmacy
Berberine: A natural modulator of immune cells in multiple sclerosis

Esmaeil Yazdanpanah,Sepehr Dadfar,Alireza Shadab,Niloufar Orooji,MohammadHossein Nemati,Alireza Pazoki,Seyed‐Alireza Esmaeili,Rasoul Baharlou,Dariush Haghmorad

DOI: https://doi.org/10.1002/iid3.1213

2024-03-15

Immunity Inflammation and Disease

Abstract:There have been considerable changes discovered in multiple sclerosis (MS) regards to the function and frequency of T cell subsets such as Th1 cells, Th17 cells, Th2 cells, Treg cells, and dendritic cells (DCs). In the current research, we reviewed the outcomes of in vitro, experimental, and clinical investigations concerning the modulatory effects that Berberine provides on the function and numbers of T cell subsets and DCs, as well as important cytokines that are involved in MS. Berberine is a benzylisoquinoline alkaloid found in such plants as Berberis vulgaris, Berberis aristata, and others, revealing a variety of pharmacological properties as a result of interacting with different cellular and molecular targets. Recent studies have shown the immunomodulatory effects of Berberine which result from its impacts on immune cells and immune response mediators such as diverse T lymphocyte subsets, dendritic cells (DCs), and different inflammatory cytokines. Multiple sclerosis (MS) is a chronic disabling and neurodegenerative disease of the central nervous system (CNS) characterized by the recruitment of autoreactive T cells into the CNS causing demyelination, axonal damage, and oligodendrocyte loss. There have been considerable changes discovered in MS regards to the function and frequency of T cell subsets such as Th1 cells, Th17 cells, Th2 cells, Treg cells, and DCs. In the current research, we reviewed the outcomes of in vitro, experimental, and clinical investigations concerning the modulatory effects that Berberine provides on the function and numbers of T cell subsets and DCs, as well as important cytokines that are involved in MS.

immunology
Berberine and Its Role in Chronic Disease

Arrigo F. G. Cicero,Alessandra Baggioni

DOI: https://doi.org/10.1007/978-3-319-41334-1_2

2016-01-01

Advances in experimental medicine and biology

Abstract:Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids. It is found in such plants as Berberis [e.g. Berberis aquifolium (Oregon grape), Berberis vulgaris (barberry), Berberis aristata (tree turmeric)], Hydrastis canadensis (goldenseal), Xanthorhiza simplicissima (yellowroot), Phellodendron amurense[2] (Amur corktree), Coptis chinensis (Chinese goldthread), Tinospora cordifolia, Argemone mexicana (prickly poppy) and Eschscholzia californica (Californian poppy). In vitro it exerts significant anti-inflammatory and antioxidant activities. In animal models berberine has neuroprotective and cardiovascular protective effects. In humans, its lipid-lowering and insulin-resistance improving actions have clearly been demonstrated in numerous randomized clinical trials. Moreover, preliminary clinical evidence suggest the ability of berberine to reduce endothelial inflammation improving vascular health, even in patients already affected by cardiovascular diseases. Altogether the available evidences suggest a possible application of berberine use in the management of chronic cardiometabolic disorders.

medicine, research & experimental,biology
Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence

Xinmei Xu,Huan Yi,Jiasi Wu,Tingting Kuang,Jing Zhang,Qi Li,Huan Du,Tong Xu,Guihua Jiang,Gang Fan

DOI: https://doi.org/10.1016/j.biopha.2020.110984

2021-01-01

Abstract:The increased incidence of metabolic diseases (e.g., diabetes and obesity) has seriously affected human health and life safety worldwide. It is of great significance to find effective drugs from natural compounds to treat metabolic diseases. Berberine (BBR), an important quaternary benzylisoquinoline alkaloid, exists in many traditional medicinal plants. In recent years, BBR has received widespread attention due to its good potential in the treatment of metabolic diseases. In order to promote the basic research and clinical application of BBR, this review provides a timely and comprehensive summary of the pharmacological and clinical advances of BBR in the treatment of five metabolic diseases, including type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease, hyperlipidemia, and gout. Both animal and clinical studies have proved that BBR has good therapeutic effects on these five metabolic diseases. The therapeutic effects of BBR are based on regulating various metabolic aspects and pathophysiological procedures. For example, it can promote insulin secretion, improve insulin resistance, inhibit lipogenesis, alleviate adipose tissue fibrosis, reduce hepatic steatosis, and improve gut microbiota disorders. Collectively, BBR may be a good and promising drug candidate for the treatment of metabolic diseases. More studies, especially clinical trials, are needed to further confirm its molecular mechanisms and targets. In addition, large-scale, long-term and multi-center clinical trials are necessary to evaluate the efficacy and safety of BBR in the treatment of these metabolic diseases.

pharmacology & pharmacy,medicine, research & experimental
Biological properties and clinical applications of berberine

Danyang Song,Jianyu Hao,Daiming Fan

DOI: https://doi.org/10.1007/s11684-019-0724-6

2020-04-25

Frontiers of Medicine

Abstract:Berberine, an isoquinoline alkaloid isolated from the Chinese herb Coptis chinensis and other Berberis plants, has a wide range of pharmacological properties. Berberine can be used to treat many diseases, such as cancer and digestive, metabolic, cardiovascular, and neurological diseases. Berberine has protective capacities in digestive diseases. It can inhibit toxins and bacteria, including Helicobacter pylori, protect the intestinal epithelial barrier from injury, and ameliorate liver injury. Berberine also inhibits the proliferation of various types of cancer cells and impedes invasion and metastasis. Recent evidence has confirmed that berberine improves the efficacy and safety of chemoradiotherapies. In addition, berberine regulates glycometabolism and lipid metabolism, improves energy expenditure, reduces body weight, and alleviates nonalcoholic fatty liver disease. Berberine also improves cardiovascular hemodynamics, suppresses ischemic arrhythmias, attenuates the development of atherosclerosis, and reduces hypertension. Berberine shows potent neuroprotective effects, including antioxidative, antiapoptotic, and anti-ischemic. Furthermore, berberine exerts protective effects against other diseases. The mechanisms of its functions have been extensively explored, but much remains to be clarified. This article summarizes the main pharmacological actions of berberine and its mechanisms in cancer and digestive, metabolic, cardiovascular, and neurological diseases.

oncology,medicine, research & experimental
Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends

Tapan Behl,Sukhbir Singh,Neelam Sharma,Ishrat Zahoor,Ali Albarrati,Mohammed Albratty,Abdulkarim M. Meraya,Asim Najmi,Simona Bungau

DOI: https://doi.org/10.3390/molecules27123705

IF: 4.6

2022-06-09

Molecules

Abstract:Traditionally, herbal compounds have been the focus of scientific interest for the last several centuries, and continuous research into their medicinal potential is underway. Berberine (BBR) is an isoquinoline alkaloid extracted from plants that possess a broad array of medicinal properties, including anti-diarrheal, anti-fibrotic, antidiabetic, anti-inflammatory, anti-obesity, antihyperlipidemic, antihypertensive, antiarrhythmic, antidepressant, and anxiolytic effects, and is frequently utilized as a traditional Chinese medicine. BBR promotes metabolisms of glucose and lipids by activating adenosine monophosphate-activated protein kinase, stimulating glycolysis and inhibiting functions of mitochondria; all of these ameliorate type 2 diabetes mellitus. BBR has also been shown to have benefits in congestive heart failure, hypercholesterolemia, atherosclerosis, non-alcoholic fatty liver disease, Alzheimer's disease, and polycystic ovary syndrome. BBR has been investigated as an interesting pharmacophore with the potential to contribute significantly to the research and development of novel therapeutic medicines for a variety of disorders. Despite its enormous therapeutic promise, the clinical application of this alkaloid was severely limited because of its unpleasant pharmacokinetic characteristics. Poor bioavailability, limited absorption, and poor water solubility are some of the obstacles that restricted its use. Nanotechnology has been suggested as a possible solution to these problems. The present review aims at recent updates on important therapeutic activities of BBR and different types of nanocarriers used for the delivery of BBR in different diseases.

chemistry, multidisciplinary,biochemistry & molecular biology
Berberine on the Prevention and Management of Cardiometabolic Disease: Clinical Applications and Mechanisms of Action

Richard Y. Cao,Yuntao Zheng,Ying Zhang,Lingling Jiang,Qing Li,Wanqun Sun,Wenqin Gu,Weifeng Cao,Linyan Zhou,Hongchao Zheng,Jian Yang

DOI: https://doi.org/10.1142/S0192415X21500762

2021-01-01

Abstract:Berberine is an alkaloid from several medicinal plants originally used to treat diarrhea and dysentery as a traditional Chinese herbal medicine. In recent years, berberine has been discovered to exhibit a wide spectrum of biological activities in the treatment of diverse diseases ranging from cancer and neurological dysfunctions to metabolic disorders and heart diseases. This review article summarizes the clinical practice and laboratory exploration of berberine for the treatment of cardiometabolic and heart diseases, with a focus on the novel insights and recent advances of the underlying mechanisms recognized in the past decade. Berberine was found to display pleiotropic therapeutic effects against dyslipidemia, hyperglycemia, hypertension, arrhythmia, and heart failure. The mechanisms of berberine for the treatment of cardiometabolic disease involve combating inflammation and oxidative stress such as inhibiting proprotein convertase subtilisin/kexin 9 (PCSK9) activation, regulating electrical signals and ionic channels such as targeting human ether-a-go-go related gene (hERG) currents, promoting energy metabolism such as activating adenosine monophosphate-activated protein kinase (AMPK) signaling pathway, modifying gut microbiota to promote transforming of berberine into its intestine-absorbable form, and interacting with non-coding RNAs via targeting multiple signaling pathways such as AMPK, mechanistic target of rapamycin (mTOR), etc. Collectively, berberine appears to be safe and well-tolerated in clinical practice, especially for those who are intolerant to statins. Knowledge from this field may pave the way for future development of more effective pharmaceutical approaches for managing cardiometabolic risk factors and preventing heart diseases.
[Contraception using 3-monthly injections of Depo-Provera].

C. Revaz,H. Welti,A. Dettling

Abstract:The injectable contraceptive Depo-Provera is used by about 1 million women mostly in Europe. It consists of an injection of 150 mg of medroxyprogesterone acetate every 3 months; the drug suppresses ovulation modifies the endometrium and the consistency of cervical mucus. In a clinical study of 100 cases effectiveness proved to be excellent the Pearl index being between 0-0.77 comparable to that for oral contraceptives (OCs). Side effects are minimal and limited to nausea and headache; there can however be an increase in bodyweight. The major complications are irregular bleeding and spotting; metrorrhagia intervenes in 70% of cases and amenorrhea in 55-75% of cases. These inconvenients can be eliminated by administration of estrogen by anticipating the next injection of Depo-Provero or by administering an oral contraceptive during the first 3-6 cycles after the first injection. Reversibility after Depo-Provera is slower than with other methods; ovulation reappears spontaneously 6-12 months after the last injection. In difficult cases ovulation can be reestablished with ovulation inductors. Continuation rate is 60-75% of users after 1 year and 45-60% of users after 2 years a rate comparable to that for OCs. It has not been proven that Depo-Provera has carcinogenic effects on the cervical and breast tissues.
Berberine: New perspectives for old remedies

Micol Tillhon,Luis M. Guamán Ortiz,Paolo Lombardi,A. Ivana Scovassi

DOI: https://doi.org/10.1016/j.bcp.2012.07.018

IF: 6.1

2012-11-01

Biochemical Pharmacology

Abstract:Chemical compounds derived from plants have been used since the origin of human beings to counteract a number of diseases. Among them, the natural isoquinoline alkaloid berberine has been employed in Ayurvedic and Chinese Medicine for hundreds of years with a wide range of pharmacological and biochemical effects. More recently, a growing body of reports supports the evidence that berberine has anticancer effects, being able to block the proliferation of and to kill cancer cells. This review addresses the properties and therapeutic use of berberine and focuses on the recent advances as promising anticancer drug lead.

pharmacology & pharmacy
Learning from berberine: Treating chronic diseases through multiple targets

Jing Yao,WeiJia Kong,JianDong Jiang

DOI: https://doi.org/10.1007/s11427-013-4568-z

2014-10-30

Science China Life Sciences

Abstract:Abstract Although advances have been made, chemotherapy for chronic, multifactorial diseases such as cancers, Alzheimer’s disease, cardiovascular diseases and diabetes is far from satisfactory. Agents with different mechanisms of action are required. The botanic compound berberine (BBR) has been used as an over-the-counter antibacterial for diarrhea in China for many decades. Recent clinical studies have shown that BBR may be therapeutic in various types of chronic diseases. This review addresses BBR’s molecular mechanisms of action and clinical efficacy and safety in patients with type 2 diabetes, hyperlipidemia, heart diseases, cancers and inflammation. One of the advantages of BBR is its multiple-target effects in each of these diseases. The therapeutic efficacy of BBR may reflect a synergistic regulation of these targets, resulting in a comprehensive effect against these various chronic disorders. The safety of BBR may be due to its harmonious distribution into those targets. Although the single-target concept is still the principle for drug discovery and research, this review emphasizes the concept of a multiple target strategy, which may be an important approach toward the successful treatment of multifactorial chronic diseases.

biology

HIV-associated malignancies.

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases

Berberine: a potential phytochemical with multispectrum therapeutic activities

Berberine: A Promising Treatment for Neurodegenerative Diseases

Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy

Pharmacological effects of berberine and its derivatives: a patent update

The complexity of ranking

Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential

Berberine influences multiple diseases by modifying gut microbiota

Pharmacological effects of Berberine – A Chinese medicine, against xenobiotics toxicity

Anti‐inflammatory and immune‐modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota

Berberine: A natural modulator of immune cells in multiple sclerosis

Berberine and Its Role in Chronic Disease

Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence

Biological properties and clinical applications of berberine

Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends

Berberine on the Prevention and Management of Cardiometabolic Disease: Clinical Applications and Mechanisms of Action

[Contraception using 3-monthly injections of Depo-Provera].

Berberine: New perspectives for old remedies

Learning from berberine: Treating chronic diseases through multiple targets